Buscar en
Medicina Clínica (English Edition)
Toda la web
Inicio Medicina Clínica (English Edition) Surgical approach of non-small cell lung cancer with extrapulmonary metastasis
Journal Information
Vol. 153. Issue 3.
Pages 115-121 (August 2019)
Share
Share
Download PDF
More article options
ePub
Visits
0
Vol. 153. Issue 3.
Pages 115-121 (August 2019)
Review
DOI: 10.1016/j.medcle.2019.02.025
Surgical approach of non-small cell lung cancer with extrapulmonary metastasis
Abordaje quirúrgico del carcinoma broncogénico de células no pequeñas con metástasis extrapulmonar
Visits
...
Gemma María Muñoz Molinaa,
Corresponding author
gmunozmolina@yahoo.es

Corresponding author.
, Ana Patricia Ovejero Díaza, Luis Gorospe Sarasúab
a Cirugía Torácica, Hospital Ramón y Cajal, Madrid, Spain
b Radiodiagnóstico, Hospital Ramón y Cajal, Madrid, Spain
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Tables (2)
Table 1. Recommendations for the treatment of brain metastases.
Table 2. Recommendations for the treatment of adrenal metastases.
Show moreShow less
Abstract

Bronchogenic carcinoma is the leading cause of death due to cancer worldwide. Nearly 75% of patients have a disseminated carcinoma at diagnosis. Up to 50% of patients with a localized disease will develop metastasis. Nevertheless, the current scientific evidence has demonstrated that when the metastatic disease is limited, particularly in specific locations such as the brain and the adrenal glands, a multidisciplinary approach with radical intent could achieve a longer survival.

This review analyses the clinical evidence available in the literature that supports the treatment of both the primary and the metastatic disease, as well as the preoperative study and the most widely accepted indications.

Keywords:
Non small-cell lung cancer
Oligometastases
Cerebral metastases
Adrenal metastases
Resumen

El carcinoma broncogénico es la causa más frecuente de muerte por cáncer en el mundo. Cerca del 75% de los pacientes presentan enfermedad diseminada en el momento del diagnóstico. Hasta un 50% de los pacientes con enfermedad localizada al inicio desarrollarán metástasis. Sin embargo, la evidencia científica actual ha demostrado que, cuando la enfermedad metastásica es limitada y sobre todo en determinadas localizaciones como la cerebral y la suprarrenal, su abordaje multidisciplinar con intención radical puede prolongar la supervivencia.

El presente artículo revisa la evidencia clínica bibliográfica existente que apoya el tratamiento, no solo de la enfermedad primaria sino de la metastásica, además del estudio preoperatorio y las indicaciones más aceptadas.

Palabras clave:
Carcinoma broncogénico de células no pequeñas
Oligometástasis
Metástasis cerebral
Metástasis suprarrenal

Article

These are the options to access the full texts of the publication Medicina Clínica (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Subscribe
Subscribe to

Medicina Clínica (English Edition)

Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos